Patient Engagement Advisory Committee (PEAC) October 30, 2024 | 10AM- 5PM EST

https://www.fdalive.com/peac/?utm_medium=email&utm_source=govdelivery Patient-Centered Informed Consent in Clinical Study of FDA-Regulated Medical Products Meeting Date: Wednesday, October 30, 2024, 10:00 a.m. to 5:00 p.m. ET Location: Webcast Registration: Registration is only required to participate in the breakout sessions. The U.S. Food and Drug Administration (FDA) is announcing the Patient Engagement Advisory Committee (PEAC) meeting, where PEAC will discuss and make recommendations on patient-centered informed consent in clinical study of FDA-regulated medical products. The topics for discussion include: The informed consent process, and Factors to consider when communicating informed consent to clinical study participants to increase the likelihood of participants understanding the key elements of research.